Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication
NCT ID: NCT02833623
Last Updated: 2016-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
310 participants
INTERVENTIONAL
2016-10-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour
NCT01398696
Use of Teach Back to Improve Comprehension of Discharge Instructions for Emergency Patients With Limited Health Literacy
NCT01968291
Impact of a Communication Toolkit on Antibiotic Prescribed by General Practitioners: a Randomised Trial
NCT04562571
Impact Evaluation of the Pilot SMS Mother Reminder System
NCT02121821
Use of a Training Video to Teach Medical Students About Health Literacy
NCT01460953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Short-message-based Re-education group
Patients receive oral and written education before H. pylori eradication therapy at first, then they receive short message re-education twice per day during therapy.
Both the content of the oral and written education and the short message re-education are same.
Short-message-based Re-education
conventional education group
Patients only receive oral and written education before H. pylori eradication therapy.
conventional education
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Short-message-based Re-education
conventional education
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmed diagnosis of H. pylori infection by at least one of the following methods: 13C-urea breath test, histology, rapid urease test or bacterial culture
* an intention of H. pylori eradication treatment and have written inform consent
* ability to read short messages on the mobile phone
Exclusion Criteria
* allergy to any of the drugs used in this study
* previous Helicobacter Pylori eradication treatment
* pregnancy or breastfeeding (female participants with childbearing potential were required to use medically accepted contraception for the duration of the study)
* taking antibiotics or PPIs or bismuth salts within four weeks
* previous gastrointestinal surgery
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanqing Li
Vice president of Qilu Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yanqing Li, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Qilu Hospital of Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016SDU-QILU-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.